Foresight Group has invested £3 million in MyWay Digital Health to expedite product development and broaden its global commercial reach in the digital health sector.

Information on the Target

MyWay Digital Health Ltd (MWDH) is a cutting-edge digital healthcare solutions provider focused on improving the management of long-term health conditions, particularly diabetes. Founded in 2017 as a spin-off from the University of Dundee, MWDH operates with a mission to enhance the lives of individuals suffering from chronic diseases through personalized, data-driven health technology. The Company currently employs 30 professionals across its offices in Dundee, Edinburgh, and London.

MWDH's flagship product, MyWay Diabetes, is a clinically validated digital self-management tool that seamlessly integrates with NHS systems. This platform offers personalized education, data visualization, and actionable insights, significantly improving both patient engagement and health outcomes. MWDH's innovations extend beyond diabetes to include solutions for cardiovascular health, hypertension, and weight management, truly embodying a comprehensive approach to healthcare.

Industry Overview in the UK

The UK digital health market has seen considerable growth in recent years, driven by increasing demand for innovative healthcare solutions and advancements in technology. Chronic diseases pose a significant burden on the National Health Service (NHS) and have led to an urgent